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 Tobacco expressing CLAVATA3-GFP (CLV3-GFP) secretes the 
active CLV3 peptide 
 The ER chaperone endoplasmin supports CLV3-GFP synthesis  
 Intact CLV3-GFP is rapidly degraded, also when intracellular traffic is 
inhibited  
 CLV3-GFP half-life is extended by inhibitors of ER associated 
degradation (ERAD) 







The 12 amino acid peptide derived from the Arabidopsis soluble secretory 
protein CLAVATA3 (CLV3) acts at the cell surface in a signalling system 
that regulates the size of apical meristems. The subcellular pathway 
involved in releasing the peptide from its precursor is unknown. We show 
that a CLV3-GFP fusion expressed in transfected tobacco protoplasts or 
transgenic tobacco plants has very short intracellular half-life that cannot be 
extended by the secretory traffic inhibitors brefeldin A and wortmannin. The 
fusion is biologically active, since the incubation medium of protoplasts from 
CLV3-GFP-expressing tobacco contains the CLV3 peptide and inhibits root 
growth. The rapid disappearance of intact CLV3-GFP requires the signal 
peptide and is inhibited by the proteasome inhibitor MG132 or coexpression 
with a mutated CDC48 that inhibits endoplasmic reticulum-associated 
protein degradation (ERAD). The synthesis of CLV3-GFP is specifically 
supported by the endoplasmic reticulum chaperone endoplasmin in an in 
vivo assay. Our results indicate that processing of CLV3 starts intracellularly 
in an early compartment of the secretory pathway and that ERAD could play 
a regulatory or direct role in the active peptide synthesis.  
 
Abbreviations: BFA, Brefeldin A; CLV3, clavata3; ER, endoplasmic 
reticulum; ERAD, endoplasmic reticulum associated degradation; GFP, 
green fluorescent protein;  
 
KEY WORDS: Arabidopsis thaliana; CLAVATA3; endoplasmin; ERAD; 
protein processing; protein traffic 
 
1. Introduction 
The soluble secretory protein CLAVATA3 (CLV3) cooperates with a 
number of plasma membrane proteins in a signalling mechanism that limits 
excessive proliferation of pluripotent cells in apical meristems [1]. CLV3 was 
the first discovered member of the large CLE protein family (CLE being the 
acronym for CLAVATA3/ENDOSPERM SURROUNDING REGION-related), 
short soluble proteins with a signal peptide for entry into the secretory 
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pathway [2,3]. A 12-14 amino acid peptide located in the C-terminal region 
is released post-translationally from CLE proteins and is responsible for their 
biological activities. The active 12 amino acid peptide of CLV3 [4] is 
recognized extracellularly by the ectodomains of the plasma membrane 
receptor kinases CLV1 and BAM1, in a process that also involves the co-
receptors CLV2, CORYNE and RPK2 [4-6]. The pathway and subcellular 
localization of CLV3 processing is however not easy to define [7-10], also 
because antibodies for the CLV3 or other CLE polypeptides are not 
available. CLE19 C-terminal processing involves the SOL1 protease, which 
is located in endosomes [11]. However, sol1 mutations suppress the 
phenotype generated by CLE19 overexpression but not that of CLV3 
overexpression, indicating that SOL1 is necessary for maturation of the 
former but not the latter [11]. CLV3 expressed in E. coli without its signal 
peptide and with added N-terminal Trx and His tags was processed giving 
rise to the active peptide when added to the growth medium of Arabidopsis 
seedlings [12]. Therefore, the precursor can be correctly processed 
extracellularly by secreted proteases. Other tagged versions of CLV3 or its 
C-terminal region expressed in E. coli were used to determine in vitro the 
activity of plant extracts or incubation media of plant cell cultures [9,10]. The 
results indicate that a secreted serine protease is able to perform N-terminal 
processing, while C-terminal processing may involve a progressive 
carboxypeptidase of yet unknown localization [10]. 
To determine whether, after insertion into the endoplasmic reticulum (ER) 
and removal of the signal peptide, CLV3 undergoes further processing 
before reaching the extracellular space, we have analysed the in vivo 
destiny of CLV3-GFP fusions expressed in transgenic tobacco or transiently 
in plant protoplasts. 
 
2. Materials and methods 
 
2. 1. Tobacco transformation 
 
Plasmid pAVA120, in which the cDNA coding for CLV3 had been inserted 
ahead of the GFP sequence [7] was used to excise by PstI a fragment 
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including the 35S promoter, the sequence encoding CLV3-GFP and the 35S 
terminator. This fragment was introduced into the PstI site of the pGreenII 
binary vector [13], obtaining pGreen.CLV3-GFP. Agrobacterium tumefaciens 
strain GV3101 transformed with pGreen.CLV3-GFP, was used to produce 
transgenic Nicotiana tabacum cvSR1, as described [14].  
 
2. 2. Transient expression in protoplasts and pulse-chase labelling 
 
Plasmid pAVA120 encoding CLV3-GFP or CLV3sp-GFP [7] and plasmid 
pDHA encoding mGFP5 [15] or T343F phaseolin [16] have been described. 
To produce CLV3-mGFP5, the 408 bp region between the NdeI/BsaI sites of 
pGreen.CLV3-GFP was substituted with the similarly restricted fragment 
from pDHA.mGFP5 [15]. CLV3-mGFP5 thus contains the three stabilizing 
mutations of mGFP5 [17]. The coding sequence of CLV3-FLAG, consisting 
of the CLV3 precursor immediately followed by the FLAG epitope 
(DYKDDDDK) before a stop codon, was synthesized (Integrated DNA 
Technologies) and inserted into SalI/SphI-restricted pDHA. 
Transient expression was performed in protoplasts prepared from 4-7 cm-
long leaves of wt tobacco plants cultivated in axenic condition or protoplasts 
similarly isolated from transgenic plants, using polyethylene glycol-mediated 
transfection as described [18].  Transfected protoplasts (usually 1 million l-1) 
were incubated overnight in K3 medium (Gamborg’s B5 basal medium with 
minimal organics [Sigma], supplemented with 750 mg l-1 CaCl2.2H2O, 250 
mg l-1 NH4NO3, 136.2 g l-1 sucrose, 250 mg l-1  xylose, 1 mg l-1  6-
benzylaminopurine, and 1 mg l-1  1-naphthalenacetic acid, pH 5.5), before 
pulse-labelling for 1 h with [35S]Met and [35S]Cys (Pro-Mix; Amersham 
Biosciences, final concentration of 100 Ci mL-1) at 25°C, in K3 medium 
supplemented with 150 µg ml-1 bovine serum albumin. Chase was 
performed by adding unlabelled Met and Cys to final concentrations of 10 
mM and 5 mM respectively. At each chase point, three volumes of ice-cold 
W5 medium (154 mM NaCl, 5 mM KCl, 125 mM CaCl22H2O, and 5 mM 
glucose)  were added and centrifugation performed at 60 g for 10 min. 
Precipitated protoplasts and their supernatant, which contains proteins 
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secreted during pulse-chase, were collected and homogenized at 4°C by 
adding 2 volumes of ice-cold protoplast homogenization buffer [16] 
supplemented with Complete protease inhibitor cocktail (Roche). 
Treatments of protoplasts with BFA (Roche, 10 g ml-1 final, stock solution 2 
mg ml-1 in ethanol), wortmannin (Sigma-Aldrich, 10 M final, stock solution 1 
mM in dimethyl sulfoxide) or MG132 (Sigma-Aldrich, 100 M, stock solution 
10 mM in dimethyl sulfoxide) were performed by adding the inhibitors 45 min 
before pulse-labelling, and maintaining the same concentrations throughout 
the chase. For the CDC48 assay, protoplasts were transiently transfected 
with 30 g plasmid encoding CDC48wt or CDC48QQ [19], incubated 
overnight in K3 at 25°C and pulse-labelled for 1 h. Immunoselection was 
with rabbit anti-GFP serum (Life Technologies), rabbit anti-FLAG polyclonal 
antibodies (Sigma–Aldrich), or rabbit anti-phaseolin serum [16], followed by 
incubation with Protein A Sepharose (Invitrogen). Solubilization of insoluble 
material by SDS and reducing agent followed by immunoselection was 
performed as described [20]. Immunoselected proteins were separated by 
15% acrylamide SDS-PAGE in reducing conditions, using 14C-methylated 
proteins (Sigma-Aldrich) as molecular mass markers. Radioactive proteins 
were detected and quantified either using the Starion FLA-9000 
phosphoimager system and Multi Gauge Ver.2.0 (Fujifilm), or by treatment 
with 2,5-diphenyloxazole and fluorography as described [16] and 
quantitation using TotalLab Quant (TotalLab, Newcastle upon Tyne, UK) or 
ImageJ open source software (imagej.net). 
 
2.3. Chaperone assay 
 
Each plasmid mixture was composed of 20 g of plasmid encoding CLV3-
GFP or mGFP5, 20 g encoding Arabidopsis endoplasmin [18] or tobacco 
BiP (pDE800; [21]), and the needed amount of plasmid encoding -amylase 
(pNL200; [21]) as a secretory protein with no chaperone activity, to reach 
final 60 g and thus maintain a roughly constant amount of total 
recombinant protein translocated into the ER lumen. After transfection and 4 
h recovery, protoplasts were incubated for 16 h in K3 medium in the 
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presence of 20 g mL-1 tunicamycin (Sigma, from a 5 mg mL-1 stock 
dissolved in 10 mM NaOH) or an equivalent volume of 10 mM NaOH. 
Protoplasts were then pulse-labelled for 1 hr at 25°C with the [35S]Met and 
[35S]Cys mixture, homogenized as described above and subjected to 
immunoselection using anti-GFP, anti-BiP [16] or anti-endoplasmin [18]. 
After SDS-PAGE and fluorography, intensities of bands were measured 
using TotalLab Quant software. 
 
2.4. Protein blot 
 
When needed, BFA or wortmannin was added to the protoplast incubation 
medium 1 h after transfection at the concentrations described above and 
maintained at the same concentration throughout the incubation. Protoplast 
homogenization was performed as described above. To analyze proteins 
from plants, total proteins were extracted from plant tissues by 
homogenization in ice-cold plant homogenization buffer (200 mM NaCl, 1 
mM EDTA, 0.2% Triton X-100, 2% 2-mercaptoethanol, 100 mM tris-Cl pH 
7.8, supplemented with Complete protease inhibitor cocktail), using a 
buffer/fresh tissue ratio of 4 ml/g. After centrifugation at 1,500 g, 4°C for 10 
min, the resulting supernatant was considered as the total protein extract. 
For protein blot, proteins were separated by SDS-PAGE and then 
electrotransferred into nitrocellulose membrane (PerkinElmer). Protein 
Molecular Weight Markers (Fermentas) were used as molecular mass 
markers. Proteins were detected using rabbit anti-GFP polyclonal serum 
(A6455, 1:2,000 dilution, Molecular Probes) or rabbit anti-phaseolin 
polyclonal serum raised against phaseolin purified from bean cotyledons 
([16], 1:5,000 dilution) and Super West Pico chemiluminescence substrate 
(Pierce). Chemiluminescence was detected using the ChemiDoc XRS+ 
Imaging System (BioRad). 
 
2.5. Fluorescence microscopy 
 
Confocal laser scanning microscopy of shoot apex of transgenic tobacco 
expressing CLV3-GFP was performed using a Nikon Eclipse Ti2 
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microscope, equipped with a Nikon A1+ laser scanning device (Nikon, 
http://www.nikon.com/products/microscope-
solutions/lineup/confocal/a1/index.htm). GFP and chlorophyll were excited 
with the 488 nm laser and the emission was collected at 505-535 nm and 
620-700 nm, respectively using the GaAsP A1-DUVB-2 tunable emission 
detector. The pinhole was set to 1.2 airy unit. Images were acquired by a 
CFI PLAN APO 20X VC dry objective and were analyzed using Fiji software 
(https://fiji.sc/). For fluorescence microscopy, transfected tobacco 
protoplasts were incubated for 24 h in K3 medium, concentrated by the 
addition of three volumes W5 medium followed by centrifugation at 60 g for 
10 min, and then observed by epifluorescence microscopy using a Zeiss 
Axiovert 200M microscope (Carl Zeiss) equipped for epifluorescence and 




Protoplasts isolated from CLV3-GFP transgenic tobacco were incubated 
overnight in K3 before adding MG132 to 100 M final concentration, or an 
equivalent volume of dimethyl sulfoxide as a control. After 2 h incubation, 
immunocytochemistry was performed as described [22] except that the anti-
GFP primary antibody was added at 1:1,000 dilution. Cells were visualized 
with a Zeiss PALM Microbeam Axio-observer.Z1 fluorescence microscope 
equipped with a 633 oil-immersion objective. Images were collected with an 
AxioCam MRm 60N-C 1”1, ox camera (Zeiss) and visualized with AxioVision 
software. 
 
2.7. Subcellular fractionation 
Subcellular fractionation was performed by isopycnic gradient 
ultracentrifugation. Young leaves of transgenic tobacco expressing CLV3-
GFP were homogenized with buffer without detergent (12% sucrose, 10 mM 
KCl, 2 mM MgCl2, 100 mM tris-Cl, pH 7.8). About 1 ml of homogenate was 
loaded in the top of a 16-55% (w/w) continuous sucrose gradient. After 
ultracentrifugation at 141,000g for 4 h at 4°C, fractions of 780 µl were 
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collected. An equal aliquot of each fraction was separated by SDS- PAGE 
and then analyzed by protein blot with anti-GFP antiserum. 
 
 
2.8. Root growth assay 
Seeds of Arabidopsis thaliana (Col-0) were sterilized as described [23] and 
imbibed in sterile distilled water at 4°C in dark for 2 days before plating on 
half-strength MS basal salts medium (Sigma-Aldrich, USA), pH 5.8, plus 1% 
sucrose, 0.5 g l-1 MES (Merck, Germany) and 1.5% agar. Three million 
protoplasts isolated from transgenic CLV3-GFP or wt tobacco plants were 
incubated for 3 days at 25°C in the dark. These protoplast incubation media 
or 50 nM CLV3P synthetic peptide were added to the MS substrate before 
pouring it. Seedlings were grown in a vertical position at 25 °C and 16-h light 
⁄ 8-h dark photoperiod for 10 days before root length measurement. 
 
2.9. LC MS/MS analysis 
 
Incubation medium of about 6 million protoplasts isolated from CLV3-GFP 
transgenic or wt protoplasts incubated for 3 days at 25°C in the dark, was 
precipitated with an equal volume of TCA (100%). After two washes with cold 
acetone the pellets were resuspended in 100 l of double-distilled water, 
samples were diluted 1:10 with a solution acetonitrile:water (60:40) with 0.1% 
formic acid. Ten l of sample were analysed using an Acquity Ultra-
performance liquid chromatographer coupled with Quattro Premiere XE, a 
triple quadrupole, using a Waters BEH C18 column (1.7 µm, 2.1 x 50 mm) 
equipped with a guard column of the same type (Waters Corporation, Milford, 
USA). The separation was carried out in programmed condition with a flow 
rate of 0.2 ml min-1 and mobile phase consisting of water/formic acid 0.1% 
(A) and acetonitrile/formic acid 0.1% (B). The gradient was T0 min: 97% A, 
3% B, T1 min: 97% A, 3% B, T4 min: 30% A, 70% B, T5 min: 97% A, 3% B. 
All analyses were conducted in positive electrospray ionization mode (ESI+) 
using selected reaction monitoring (SRM). The optimized mass spectrometer 
conditions for CLV3 were: Transition (m/z) 656,8 > 503,0, Cone Voltage 32 
V, Collision Energy 24 eV; capillary voltage 2.5 kV. Nitrogen was used as 
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desolvation gas (350 l h-1) and cone gas (150 l /h-1) while the collision gas 
was argon (flow rate of 0.35 ml min-1). Data acquisition processing was 






3.1. CLV3-GFP undergoes rapid proteolysis in vivo 
 
CLV3-GFP [7] is composed of CLV3 fused to the N-terminus of mGFP4. 
A similar construct under the control of the endogenous CLV3 promoter is 
able to rescue clv3 mutant Arabidopsis plants [8], indicating that fusion to 
GFP does not affect the production of the active peptide and can therefore 
be used to investigate the time-course of GFP processing. The deleterious 
effects of CLV3 overexpression in Arabidopsis make biochemical and cell 
biology analysis very difficult. We therefore transiently expressed CLV3-
GFP in tobacco protoplasts. We first determined whether CLV3-GFP could 
be detected by immunoprecipitation. GFP with a transient N-terminal signal 
peptide for translocation into the ER was also expressed, as a control 
secretory form of GFP (mGFP5, [15]). Transfected protoplasts were 
incubated for 1 h with a mixture of [35S]Met and [35S]Cys and proteins were 
immunoselected with anti-GFP serum from a total cell homogenate (Fig. 
1A). Major polypeptides with the predicted molecular mass were 
immunoselected: 35 kD (filled arrowhead, CLV3-GFP) and 28 kD (empty 
arrowhead, mGFP5). 
To elucidate the destiny of CLV3-GFP, protoplasts were subjected to 1 h 
pulse followed by different chase time-points. Intact CLV3-GFP rapidly 
disappeared during the chase, with no signs of its secretion or intracellular 
accumulation of immunoprecipitable fragments (Fig. 1B). mGFP5 is an 
improved GFP, with three point mutations to avoid misfolding and 
precipitation at temperatures above 30°C [17].  mGFP4, which is the GFP 
version present in CLV3-GFP, is instead the unmodified version. Although 
constructs containing mGFP4 are widely used in plant biology (for CLV3 see 
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[7, 8]) and the experiments presented here are conducted at 25°C, we 
produced two new CLV3 fusions. CLV3-mGFP5, contains the three 
stabilizing point mutations of mGFP5, whereas CLV3-FLAG was 
constructed by adding at the end of the CLV3 precursor the DYKDDDDK 
FLAG epitope, followed by a stop codon. In protoplasts, CLV3-mGFP5 
rapidly disappeared during the chase, without any detectable secretion both 
in tobacco (Fig. 1C) and Arabidopsis (Fig. S1) protoplasts. CLV3-FLAG was 
also not secreted, even if it was intracellularly slightly more stable than the 
GFP fusions (Fig. 1D). About 50% of newly synthesized CLV3-FLAG were 
lost in the first 2h of chase, compared to 80% in the case of CLV3-GFP (Fig. 
1E). Therefore, the appended sequence has some influence on the rate of 
disappearance, but the lack of secretion of intact polypeptides is a common 
characteristic of the three fusions tested and none of them seems to have 
high intracellular stability. Subsequent experiments were performed using 
CLV3-GFP. 
As expected and shown previously [15], newly synthesized mGFP5 is 
gradually secreted by protoplasts during the chase (Fig. 2A). To determine 
whether the synthesis of CLV3-GFP has an unexpected negative effect on 
the secretory pathway, we therefore co-expressed mGFP5 and CLV3-GFP. 
The CLV3 fusion does not inhibit mGFP5 secretion (Fig. 2B). To verify 
whether translocation into the ER is necessary for CLV3-GFP degradation, 
a construct in which the CLV3 signal peptide has been deleted (CLV3sp-
GFP, [7]) was expressed. CLV3sp-GFP was much more stable than CLV3-
GFP (Fig. 2C, and compare with panel 2B), indicating that the 
disappearance of CLV3-GFP requires a transient signal peptide for insertion 
into the ER. 
To confirm the pulse-chase results, transfected protoplasts were 
analysed by protein blot, which measures steady state protein levels, and by 
fluorescence microscopy, which detects active GFP. Protein blot indicated 
that a much higher amount of CLV3sp-GFP than CLV3-GFP was present 
in protoplasts at 24h after transfection, the latter likely representing only the 
molecules synthesized during the last 1–2 h before homogenization (Fig. 
2D). No secreted CLV3-GFP was detected (Fig. 2D, out; the very small 
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amount of CLV3sp-GFP in the incubation medium was most probably due 
to the unavoidable contamination by material from a small proportion of 
dead protoplasts). Consistently, microscopy showed clear fluorescence in 
protoplasts expressing CLV3sp-GFP, which also accumulated in the 
nucleus as often occurs when free GFP or its fusions with short 
polypeptides are expressed, but practically no fluorescence in those 
expressing CLV3-GFP (Fig. 3). Therefore, the instability detected by pulse-
chase was confirmed by analysis of the CLV3-GFP steady-state 
accumulation. 
 
3.2. CLV3-GFP degradation is not inhibited by brefeldin A or wortmannin 
 
To acquire information on the pathway followed by CLV3-GFP before its 
disappearance, perturbators of the biosynthetic secretory pathway were 
used. Wortmannin inhibits receptor-mediated protein sorting from the Golgi 
complex to vacuoles, causing default secretion of several vacuolar proteins 
[24]. The bean vacuolar storage protein phaseolin is cleaved into fragments 
corresponding approximately to half of the polypeptide upon sorting into the 
vacuole, but not when a mutated form is secreted [16,25] and was therefore 
used as a control. Wortmannin inhibited the vacuole-mediated fragmentation 
of phaseolin (Fig. 4A, asterisk indicates intact phaseolin, vertical bar 
indicates phaseolin fragments) but had no effect on the disappearance of 
CLV3-GFP (Fig. 4B). Brefeldin A (BFA) causes deregulated fusion of Golgi 
cisternae with the ER and inhibits further traffic of newly synthesized 
proteins, thus blocking both secretion and vacuolar sorting of proteins that 
traffic through the Golgi complex [14-16]. The drug thus inhibits secretion of 
mGFP5 and vacuolar delivery of a modified derivative with an added 
vacuolar sorting signal [14,15], as well as the vacuole-mediated, post-
translational fragmentation of phaseolin [16]. The inhibition of phaseolin 
fragmentation by BFA can be visualized by pulse-chase (Fig. 4C and Fig. 
S2) and causes high accumulation of intact phaseolin detected by protein 
blot (Fig. 4A). Conversely, BFA did not alter CLV3-GFP stability apart from a 
slight stabilization at 1 h chase (Fig. 4D and Fig. S2). 
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It can be concluded that the disappearance of CLV3-GFP does not 
require Golgi-mediated delivery to the vacuole and seems to occur before 
traffic out of the ER, as also suggested by the observation that this 
disappearance is very rapid when compared to mGFP secretion (see Fig. 
2B). 
 
3.3. The active CLV3 peptide is produced in transgenic tobacco 
constitutively expressing CLV3-GFP 
 
To verify whether the CLV3-GFP degradation occurring in protoplasts 
indeed leads to the formation of the active CLV3 peptide, the fusion protein 
was expressed in transgenic tobacco under the 35S promoter. These 
transgenic plants grew normally, not showing any marked visible phenotype. 
Pulse-chase of protoplasts prepared from transgenic leaves indicated that 
newly synthesized CLV3-GFP rapidly disappeared, as upon transient 
expression (Fig. 5A). Even after very short pulse, no fragmentation products 
recognized by the anti-GFP antiserum could be detected (Fig. 5B). 
When supplemented to the medium of growing Arabidopsis seedling, a 
chemically-synthesized dodecapeptide corresponding to the functional  
CLV3 dodecapeptide (RTVPSGPDPLHH, CLV3p12, [12]) causes the 
consumption of root meristems, resulting in shortened root length indicative 
of CLV3 activity [4,12,26]. The culture medium of CLV3-GFP transgenic 
tobacco protoplasts was therefore supplemented to germinating Arabidopsis 
seeds. After 10 days growth, a marked reduction in root length, compared to 
the untreated control, was clearly detectable (Fig. 5C) and comparable to 
that obtained by supplementing the CLV3p12 synthetic peptide to a final 50 
nM concentration (Fig. 5D). Using a LC-MS/MS assay, we verified the 
presence of the expected CLV3 peptide in the culture medium of transgenic 
protoplasts. The identification was based on comparison of the 
corresponding CLV3p12 standard and the selected transition 656,8 > 503,0 
(Fig. 5E). 656,8 m/z corresponds to the double charged standard ion 
(M+2H)2+, and the 503,0 m/z product ion corresponds to the C-terminal 
fragment of the peptide (-P-L-H-H-COOH, [4]). We conclude that expression 
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of CLV3-GFP in tobacco leaves leads to the secretion of the active CLV3 
peptide. 
 
3.4. The stability of intact CLV3-GFP can be increased by inhibiting ER-
associated protein degradation 
 
The results presented above suggest that the pathway producing the 
secreted CLV3 active peptide involves rapid disappearance of the intact 
precursor, unaffected by inhibitors of secretory traffic. These features are 
typical of ER-associated degradation (ERAD), which disposes of structurally 
defective secretory proteins, usually through retrotranslocation from the ER 
into the cytosol, ubiquitination and proteasomal degradation [27]. We 
therefore verified whether inhibitors of ERAD affect the disappearance of 
CLV3-GFP. Protoplasts from transgenic tobacco were subjected to pulse-
chase in the absence or presence of the proteasomal inhibitor MG132. 
Already at the end of the pulse, a higher amount of newly synthesized 
CLV3-GFP was immunoselected from MG132-treated protoplasts (Fig. 6A). 
To verify whether the effect was protein-specific, the same treatments were 
performed on protoplasts expressing 418 phaseolin, which is not an ERAD 
substrate [25]. MG132 caused a marked decrease of recovered 418 
phaseolin at the end of pulse (Fig 6B). This is consistent with the fact that in 
mammalian systems MG132 stabilizes ERAD substrates but also rapidly 
inhibits protein synthesis [28,29], and indicates that the partial stabilizing 
effect of MG132 on CLV3-GFP is specific. The progressive disappearance 
of CLV3-GFP during the chase was also partially inhibited by MG132 (Fig. 
6C). 
Given the results of biochemical analysis, we tested whether MG132 
allowed us to visualize CLV3-GFP by microscopy. Analysis of intact tissues 
did not show any GFP fluorescence, neither in the meristem apex where 
CLV3 is naturally expressed nor in other cells (Fig. 7A, apex is indicated by 
the arrow). Very weak fuorescence occasionally detected in the GFP 
channel (for example, approximately at the centre and bottom right of the 
left panel in Fig. 7A) was due to autofluorescence of probably cell wall 
polymers, since it could not be photobleached. Fluorescence in transgenic 
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protoplasts was also below the limit of visualization, consistent with the 
results of transient expression shown in Fig. 3, and was also undetectable 
upon MG132 treatment (data not shown). However, immunofluorescence 
microscopy using anti-GFP antiserum allowed the detection of specific, faint 
punctate structures that markedly increased in number and intensity upon 
MG132 treatment (Fig. 7B), confirming that the proteasome inhibitor had a 
positive effect on CLV3-GFP stability. Double immunofluorescence with anti-
GFP and anti-SEC21 (a Golgi marker; [30-32]) indicated that the structures 
containing CLV3-GFP were distinct from Golgi stacks (Fig. 7C). Subcellular 
fractionation by isopycnic gradient ultracentrifugation (Fig. 7D) showed co-
fractionation of CLV3-GFP with the ER chaperone BiP [16], in subcellular 
fractions with the expected density for the ER [16]. It can be concluded that 
the punctate structures containing CLV3-GFP represent transient points of 
accumulation of the newly synthesized recombinant protein within the ER, 
possibly just before disposal by ERAD. 
Usually, ERAD involves an ubiquitin-interacting AAA-ATPase, designated 
CDC48 [33]. CDC48 is part of a ternary complex that contributes to 
retrotranslocation from the ER lumen by pulling the defective proteins from 
the cytosolic face of the ER membrane translocation channel [34]. 
Protoplasts prepared from transgenic plants expressing CLV3-GFP, or 418 
phaseolin as a control, were transiently transfected with the plasmid 
encoding wild type CDC48 (CDC48wt) or a mutated form (CDC48QQ) that 
impairs the retro-translocation process also in plant cells [19]. Twelve hours 
after transfection, protoplasts were pulse-labelled for 1 h before 
homogenization and immunoprecipitation. The mutated CDC48 did not 
affect the amount of newly synthesized 418, while it increased by about 
25% that of CLV3-GFP (Fig. 8). Altogether, the results presented in Figures 
6, 7 and 8 support a role of ERAD in the rapid disappearance of the CLV3 
precursor. 
We analysed the CLV3 sequence using the Pcleavage proteasome 
cleavage prediction program (Pcleavage: 
http://www.imtech.res.in/raghava/pcleavage/; [35]). Analysis based on in 
vitro constitutive proteasome data predicts cleavages that would generate 
the active CLV3 dodecapeptide, but also its further fragmentation at an 
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internal Val residue (Fig.S3A).  Analysis based on MHC class I ligands 
predicts the formation of an 18-residue fragment containing the active CLV3 
dodecapeptide (Fig.S3B).  
 
3.5. Overexpression of endoplasmin specifically relieves the ER stress 
inhibition of CLV3-GFP synthesis 
 
The shepherd Arabidopsis mutant has greatly reduced levels of the HSP90 
chaperone of the ER, endoplasmin (also termed glucose regulated protein 
94, GRP94), because of a T-DNA insertion [18,36]. Shepherd has shoot and 
flower phenotypes that resemble those of loss of function mutants of CLV 
genes, in particular CLV3, and cannot be rescued by CLV3 overexpression 
[36], indicating that endoplasmin is directly or indirectly required for the 
activity of the CLV system. 
We therefore verified whether a role of endoplasmin could be detected 
biochemically. The assay [21] measures the ability of putative molecular 
chaperones to alleviate the decrease in the synthesis of a given secretory 
protein occurring upon the ER stress imposed by tunicamycin (Tm), an 
inhibitor of N-glycosylation that causes a general inhibition of secretory 
protein synthesis, including those that are not glycoproteins [18,21]. The 
assay indicates that the overload of chaperone work, due to the folding 
defects in proteins that need to be glycosylated, causes a shortage of 
folding helpers within the ER that can be alleviated by chaperone 
overexpression [21]. We thus co-expressed CLV3-GFP, or control mGFP5, 
with either endoplasmin, barley -amylase (as a control secretory protein 
with no chaperone activity), or BiP. The latter is the heat shock 70 ER 
resident and a very promiscuous chaperone [37]. Endoplasmin is much 
more selective than BiP: a few newly synthesized animal proteins interacting 
with it have been identified [38,39], but to date potential plant clients have 
only been postulated based on yeast two-hybrid screening [40]. 
Overexpression of BiP or endoplasmin can be visualized by 
immunoprecipitation with the respective antisera from pulse-labelled 
protoplasts and shows that, upon transfection with equal amounts of 
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plasmid, BiP synthesis is increased in our system in a similar or slightly 
higher proportion than endoplasmin (Fig. 9A).  
Tm inhibited the synthesis of CLV3-GFP or mGFP5 by 40-50% when 
these were co-expressed with-amylase (Fig. 9B). Endoplasmin fully 
abolished the Tm effect on CLV3-GFP (Fig. 9B, and 9C for quantitation). 
Endoplasmin action was stronger than that of BiP and synergistic to it (Fig. 
9B and 9C). Its effect was quantitative (Fig. 9D). In the absence of Tm 
stress, when spare chaperone activity is presumably available, the effects of 
the chaperones were much more variable in independent experiments and a 
statistically significant (P < 0.05) increase of CLV3-GFP synthesis was only 
observed when endoplasmin and BiP were co-overexpressed (Fig. 9E).  
Considering that neither mGFP5 nor CLV3-GFP are glycoproteins, these 
results confirm previous work showing that the unfolded protein response 
does not fully rescue the increased general workload of folding helpers due 
to Tm action [18,21]. Most importantly, they indicate that endoplasmin 
specifically alleviates this phenomenon for a protein fusion in which the 





4.1. Rapid intracellular processing of the CLAVATA3 precursor and a role of 
ER-associated protein degradation 
 
The biochemical and fluorescence microscopy results reported here indicate 
that CLV3 proteolytic processing starts very soon after synthesis. The two 
GFP fusions disappear faster than CLV3-FLAG, suggesting that the type of 
protein tag influences either the rate of full CLV3 maturation or that of initial 
proteolytic events that eliminate recognized epitopes. However, 
irrespectively of the appended tag, in all cases there was a rapid loss of 
immunoprecipitable fusion during the first hours of chase and no secreted 
intact CLV3 fusion was detected. 
We do not know which steps of CLV3 processing occur intracellularly: a 
major drawback of studies performed on tagged proteins is that, if the tag is 
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lost by proteolytic processing, it is impossible to trace exactly the series of 
events that follow such an event. However, the results of BFA and 
wortmannin treatments, and the fact that the CLV3 active peptide is 
produced and found extracellularly, rule out the participation of the vacuole 
and suggest that processing occurs, or at least starts, without the 
involvement of post-ER compartments of the secretory pathway. By 
fluorescence microscopy, we have been virtually unable to detect signals 
from CLV3-GFP, consistent with the rapid disappearance of the intact 
protein observed by biochemical analysis. Immunocytochemistry detected 
faint punctate structures that were distinct from Golgi stacks and increased 
in number under MG132 treatment, thus possibly representing CLV3-GFP in 
the ER lumen or at ER-proteasome attachment sites [41]. Absence of the 
signal peptide stabilizes intact CLV3-GFP, indicating that synthesis by ER-
bound polysomes, and therefore presumably translocation into the ER 
lumen, is necessary for processing. The protease SOL1, which is involved in 
CLE19 processing, is located in endosomes but not along the pathway to 
the vacuole [42]. Although this enzyme does not seem to be involved in 
CLV3 processing [42], the study confirms that processing of proteins of the 
CLE family can occur, at least in part, intracellularly. 
The stabilizing effects of the proteasome inhibitor MG132 and the ERAD 
inhibitor CDC48QQ indicate that at least a relevant proportion of CLV3-GFP 
newly synthesized polypeptides is an ERAD substrate. The biological 
activity assay and the biochemical analysis of protoplast incubation medium 
indicate that expression of CLV3-GFP in transgenic tobacco allows the 
production of the active CLV3 peptide. Different possible models may 
explain these observations. ERAD could have a physiological role in 
modulating the amount of CLV3 precursor allowed to leave the ER to 
undergo extracellular maturation, and would thus regulate the production of 
active peptide. Similarly, the fraction GABAB receptors that reaches the cell 
surface in neurons is modulated by degradation of newly synthesized 
polypeptides by the ERAD machinery [43]. The amount of intact CLV3 
precursor that reaches the cell surface would be extremely small in tobacco 
vegetative cells, but ERAD activity could be specifically regulated in 
meristematic cells to finely tune CLV3 production. Alternatively, ERAD may 
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have a direct role in producing the active CLV3 peptide, rather than 
disposing of precursors that will not produce it. This would be consistent 
with the prediction of consensus sites for proteasome cleavage compatible 
with the formation of the active dodecapeptide or a slightly larger peptide 
that could be further processed en route to secretion. Such a pathway to 
produce active CLV3 would open relevant questions regarding both the 
mechanism of secretion of the CLV3 peptide and the consistency of the 
results presented here with the available literature on CLV3. These remain 
now unresolved, probably also because to our best knowledge there are no 
other studies in which the intact CLV3 precursor or fusions containing it 
were biochemically detected by electrophoresis in plant cells, but we try 
below to define them in more detail. 
 
4.2. Consistency with known CLV3 biochemistry and cell biology 
 
The first two (out of three) Pro residues of the natural, active CLV3 peptide 
are hydroxylated to Hyp residues, the second Hyp being further modified by 
O-glycosylation with three arabinose residues [4,44]. These modifications 
are not strictly necessary for activity, but increase the interactions with the 
CLV3 receptors ([4,44]. Arabidopsis Prolyl-4-Hydroxylases occur in the ER 
and perhaps also in the Golgi apparatus [45]. Three hydroxyproline O-
arabinosyltransferases have been localized to the Golgi apparatus [46]. 
Therefore, prolyl hydroxylation rapidly occurring in the ER after synthesis is 
compatible with CLV3 being an ERAD substrate, and actually the detection 
of one major polypeptide and additionally closely migrating ones after pulse-
labelling suggests some form of processing. Arabinosylation seems instead 
to require passage through the Golgi apparatus, a trafficking step that does 
not usually occur before ERAD substrates are dislocated from the ER to the 
cytosol to be degraded by the proteasome. If proteasome processing is 
indeed along the route to the production of active CLV3, the product should 
therefore be translocated back into the secretory pathway to be O-
glycosylated in the Golgi apparatus. Peptides generated by proteolysis in 
the cytosol can be translocated into the ER lumen as part of the animal 
major histocompatibility complex (MHC) class I antigen-processing pathway 
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[47]. This leads to peptide association to the MHC class I molecules and 
deliver of the complex to the cell surface via the Golgi apparatus, to be 
presented to cytotoxic lymphocytes. It is not known whether a mechanism to 
bring peptides from the cytosol into the ER exists in plant cells. Alternatively, 
after ERAD-mediated dislocation of CLV3 from the ER to the cytosol and 
degradation by the proteasome, the resulting, active CLV3 peptide could 
follow one of the unconventional secretion pathways, which do not involve 
traffic through the ER and Golgi apparatus [48]: some plant O-glycosylation 
enzymes have also been localized in compartments involved in 
unconventional secretion [49]. A role of ERAD in the pathway to form active 
CLV3 could be relevant for explaining the involvement of the E3 ubiquitin 
ligase PUB4 in CLV3 signalling in root meristems [50], a finding defined by 
the authors as a “mystery in genetics” [51]. 
When fusions between GFP and either CLV3 or other proteins of the CLE 
family under constitutive promoter were expressed in transgenic plants or 
transiently transformed epidermal cells, microscopy revealed fluorescence 
at the cell surface, consistent with secretion [7,52]. T7-tagged CLV3 
constructs expected to be secreted were also detected in the apoplast by 
immunoelectron microscopy of roots, but when the addition of a vacuolar 
sorting peptide mutated them, they became undetectable and only 
marginally produced the typical phenotypes of CLV3 overexpression [7]. We 
hypothesize that the discrepancy with respect to our inability to detect any 
secreted intact CLV3 fusion could be only apparent, since microscopy does 
not provide information on the actual relative proportion of molecules that 
reach the cell surface as intact polypeptides. As we discussed above, this 
could be a very small fraction of newly synthesized CLV3-GFP, 
accumulating at levels detectable by fluorescence in certain tissues but 
below the limits of detection in the systems we have used, and could be not 
representative of the bulk of precursor that actually generates the peptide. 
Consistent with our results, a CLV3-YFP fusion transiently expressed in 
Nicotiana benthamiana is biochemically active but is barely detectable by 
protein blot when compared to control YFP expressed under the same 
promoter [53]. The inhibitory effect of the addition of a vacuolar sorting 
peptide on secretion and activity could result from a dominant effect of the 
 20 
vacuolar sorting signal. Although most plant soluble proteins are separated 
from those destined for secretion in the Golgi apparatus or trans-Golgi 
network, growing evidence indicates that the physical recognition of 
vacuolar sorting signals occurs already in the ER [54]. This sorting event 
could inhibit the dislocation of CLV3 fusions from the ER into the cytosol.  
When expressed in the plant secretory pathway, GFP detectable after 
pulse-labelling is usually rather stable during subsequent chase, 
independently of whether it is modified for ER retention, secretion or 
vacuolar sorting [15,55]. When fused to sequences that lead to delivery to 
the vacuole, the GFP “core” is often released from the fusion proteins, most 
probably because GFP contains a protease-sensitive site, but this core 
remains detectable and can be immunoprecipitated with anti-GFP antisera 
[15,24,55]. The core is however not detectable as a degradation product of 
an unstable secretory GFP fusion most probably delivered to the cytosol by 
ERAD [56]. The stability of GFP has also been markedly reduced by the 
addition of short sequences that target proteins for rapid proteolysis, such 
as the PEST sequences [57,58]. Our data indicate that the addition of CLV3 
similarly alters the stability of GFP. This destabilizing activity may be 
suggestive of an intrinsically disordered state of the CLV3 precursor, a 
feature that may make it a substrate for ERAD and/or favour very rapid 
processing. 
 
4.3. A possible role of endoplasmin 
 
We have shown that endoplasmin supports CLV3-GFP synthesis under ER 
stress. The effect is stronger than that of BiP, and the actions of the two 
chaperones are additive. When -amylase had been tested in the same 
assay, endoplasmin was less effective than BiP [18]. These findings point to 
endoplasmin as a specific key player in the synthesis of a protein involved in 
meristem functions and provide a first, possible biochemical explanation for 
the observed genetic relationships between endoplasmin and the CLAVATA 
system [36]. 
Endoplasmin is absent from most unicellular organisms; its complete 
knockdown is compatible with mammalian cell survival in culture but is 
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embryo-lethal, indicating that basic activities of the secretory pathway can 
dispose of this chaperone but certain functions essential for the 
establishment of specific tissue developments require it [38]. Endoplasmin 
has also peptide binding properties distinct from its chaperone activity [59], 
a characteristic that, together with immunology data on tumors [60], has 
involved endoplasmin in antigenic peptide presentation, although the 
evidence remains controversial [61,62]. BiP recognizes short peptide 
sequences enriched in bulk hydrophobic amino acids, expected to be 
masked by correct protein folding and assembly [63-65]. The recognition 
properties of endoplasmin, and of HSP90 in general, are less easily defined. 
HSP90 clients do not have clearly identifiable sequence or hydrophobicity 
features, but they have higher thermal instability than non-clients [66]. The 
assay used here does not necessarily imply a direct interaction between 
endoplasmin and CLV3-GFP. However, the observation that CLV3-GFP is 
functional but also a particularly unstable protein is in agreement with the 
characteristics of HSP90 clients defined above.  
In summary, the in vivo biochemical analysis of CLV3 synthesis reported 
here point to very rapid intracellular processing events in early 
compartments of the secretory pathway and a specific role of ERAD and 
endoplasmin, the latter possibly related to recognition properties towards 
unstable polypeptides. 
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Fig. 1. CLV3 fusions introduced into the secretory pathway disappear 
intracellularly. Tobacco leaf protoplasts were transformed with plasmids 
encoding the proteins indicated in each panel or empty pasmid (Co). After 
pulse-labelling for 1 h with [35S]Met and [35S]Cys, chase was performed for 
the indicated h, except panel A, which was pulse-labelling only. Protoplast 
homogenates or, in panels B, C and D, homogenates of protoplasts (in) and 
their incubation medium (out) were immunoselected with anti-GFP serum. 
After SDS-PAGE, radioactive proteins were detected. (E) Quantitation of 
radioactive CLV3-FLAG or CLV3-GFP at different chase points in two fully 
independent transfections and labelling experiments. In panels A-D, the 
positions of molecular mass markers (in kD) are shown at right. In panel A, 
the two images are derived from the same gel and same exposure, after 
removal of irrelevant lanes. In panel B, the two images derive from two 
different experiments. In panel D, the two images represent different gels 
exposed for the same time, from the same expression, labelling and 
immunoprecipitation experiment using the same number of protoplasts. 
 
 31 
Fig. 2.  CLV3-GFP does not perturb protein secretion and is stable when 
expressed in the cytosol. Tobacco leaf protoplasts were transformed with 
plasmids encoding the proteins indicated in each panel. A-C: after pulse-
labelling for 1 h, chase was performed for the indicated h. Protoplast 
homogenates or, in panels A and B, homogenates of protoplasts (in) and 
their incubation medium (out) were immunoselected with anti-GFP serum. 
After SDS-PAGE, radioactive proteins were detected. (D) Protoplasts were 
transfected with plasmids encoding the indicated proteins or empty plasmid 
(Co). After incubation for 24 h, protoplasts (in) or incubation medium (out) 
were analysed by SDS-PAGE and protein blot with anti-GFP serum. As a 
loading control, Ponceau S staining is also shown (bottom). Quantitation of 
CLV3sp-GFP or CLV3-GFP in two fully independent protoplast transfections 
and protein blots is shown at right. In panels A-D, the positions of molecular 
mass markers (in kD) are shown at right. 
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Fig. 3. Fluorescence of CLV3-GFP is almost undetectable in protoplasts. 
Tobacco leaf protoplasts were transfected with plasmids encoding CLV3-GFP 
or CLV3sp-GFP. After 24 h incubation, fluorescence of GFP or chloroplasts 
(Chl) was detected by epifluorescence microscopy. Two representative fields 











Fig. 4. Perturbators of the secretory pathway do not affect the stability of 
intact CLV3-GFP. Tobacco leaf protoplasts were transformed with plasmids 
encoding the proteins indicated in each panel or empty plasmid (Co). (A) 
After transformation, treatments were performed with (+) or without (-) BFA or 
wortmannin (wort) for 24 h before analysis of protoplast homogenates by 
SDS-PAGE and protein blot with anti-phaseolin serum (top). As a loading 
control, Ponceau S staining is also shown (bottom). (B) After pulse-labelling 
for 1 h, chase was for the indicated h. When indicated, the experiment was 
performed in the presence of wortmannin (wort). Homogenates of protoplasts 
(in) or their incubation medium (out) were immunoselected with anti-GFP 
serum and analysed by SDS-PAGE followed by detection of radioactive 
proteins. (C) and (D) Pulse and chase were performed with (+) or without (-) 
BFA, the homogenates immunoselected with anti-phaseolin (C) or anti-GFP 
(D) serum and proteins analysed as in (B). The positions of CLV3-GFP 
(arrowhead), intact phaseolin (asterisk) and phaseolin fragments (vertical bar) 
are indicated. In each panel, the positions of molecular mass markers (in kD) 






Fig. 5. Active CLV3 peptide is produced in transgenic tobacco constitutively 
expressing CLV3-GFP. (A) Protoplasts prepared from leaves of transgenic 
tobacco  constitutively expressing CLV3-GFP or wt tobacco were pulse-
labelled for 1 h and subjected to chase for the indicated h. Homogenates of 
protoplasts (in) and their incubation medium (out) were immunoselected with 
anti-GFP serum and analysed by SDS-PAGE and fluorography. (B) as in (A), 
but pulse was performed for only 15 or 30 min. Notice that 15 min pulse 
allows for only very low radioactive labelling. (C) Average root lengths of 10-
d-old A. thaliana seedlings (n = 40) after seeding on MS supplemented with 
incubation medium of protoplasts from wt tobacco or transgenic tobacco 
expressing CLV3-GFP, and representative images of the experiment. (D) 
Measurements as in panel A, but MS was supplemented (+clv3p) or not (-
clv3p) with the synthetic clv3p peptide. In C and D: error bar = ± SD (three 
independent biological replicates); average root lengths with significant 
differences from the relative control are marked by the asterisk (P < 0.0001 by 
Student’s t-test). (E) LC-MS/MS chromatograms of the 656,8 > 503,0 
transition of the CLV3p12 dodecapeptide (standard) and the medium of 
protoplasts isolated from leaves of wt tobacco or transgenic tobacco 
expressing CLV3-GFP. In (A) and (B), the positions of the proteins of interest 




Fig. 6.  The proteasome inhibitor MG132 increases CLV3-GFP stability. (A) 
Protoplasts isolated from leaves of wt tobacco (Co) or transgenic tobacco 
expressing CLV3-GFP were incubated in the presence or absence of MG132 
and pulse-labelled for 1 h. Protoplast homogenates were immunoselected 
with anti-GFP serum and analysed by SDS-PAGE and fluorography. The 
graph at right shows, for two fully independent experiments, the relative 
intensity of radioactive bands, setting the value in the absence of MG132 to 
100%. (B) Protoplasts isolated from leaves of transgenic tobacco expressing 
418 phaseolin were incubated in the presence or absence of MG132 and 
pulse-labelled for 1 h. Protoplast homogenates were immunoselected with 
anti-phaseolin serum and analysed by SDS-PAGE and fluorography.  (C) 
Pulse-chase of transgenic tobacco protoplast expressing CLV3-GFP. 
Homogenates (in) and protoplast incubation medium (out) were 
immunoselected with anti-GFP anti-serum and analysed by SDS-PAGE and 
fluorography. The graph at right reports quantitation of radioactive bands 
representing CLV3-GFP in three fully independent experiments, setting the 
values at 0h chase to 100%; error bar = ± SD. The positions of SDS-PAGE 
molecular mass markers (in kD) are indicated at left of the gel images. 
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Fig. 7. CLV3-GFP detectable in transgenic tobacco is in the ER. (A) shoot 
apex of transgenic tobacco expressing CLV3-GFP was analyzed by confocal 
laser scanning microscopy. Left: GFP channel, green; centre: chlorophyll 
autofluorescence, blue; right: brightfield. In each panel, the arrow points to 
the shoot meristem apex. (B) Trangenic protoplasts expressing CLV3-GFP, 
or wt protoplasts (Co) were incubated in the presence or absence of MG132, 
fixed, incubated with anti-GFP antiserum and secondary FITC-conjugated 
antibody, and analysed for FITC fluorescence. (C) Transgenic protoplasts 
expressing CLV3-GFP were incubated with mouse anti-GFP and rabbit anti-
SEC21 sera and then with the respective Texas Red- or FITC-conjugated 
secondary antibodies. Nuclei were stained with DAPI. The two images at 
bottom show controls without primary antisera. (D) Transgenic leaves 
expressing CLV3-GFP were homogenized in the presence of 12% (w/w) 
sucrose and absence of detergent. The homogenates were fractionated by 
ultracentrifugation on isopycnic sucrose gradient. Proteins in each gradient 
fraction were analyzed by SDS-PAGE and protein blot, with anti-GFP (upper 
image) or anti-BiP (bottom image) serum. Top of gradients is at left. Numbers 





Fig. 8. CDC48QQ increases CLV3-GFP stability. Protoplasts prepared from 
leaves of transgenic tobacco expressing CLV3-GFP or 418 phaseolin were 
co-transfected with plasmids encoding CDC48wt or CDC48QQ. After pulse-
labelling for 1 h with [35S]Met and [35S]Cys, protoplast homogenates were 
immunoselected with anti-GFP (CLV3-GFP) or anti-phaseolin (418) serum 
and analysed by SDS-PAGE and fluorography. For CLV3-GFP, the two 
images are derived from the same gel and same exposure, after removal of 
irrelevant lanes. The graphs show the average values of the densitometry 








Fig. 9. Endoplasmin supports the synthesis of CLV3-GFP under ER-stress. In 
all panels, tobacco leaf protoplasts transiently transformed with plasmids 
encoding the indicated proteins were pulse-labelled with [35S]Met and 
[35S]Cys for 1h. Proteins were then immunoselected from protoplast 
homogenates using the appropriate antisera and analysed by SDS-PAGE 
and fluorography. (A) Protoplasts were co-transformed with plasmids 
encoding CLV3-GFP and either of the proteins indicated at top. 
Immunoselection was with anti-endoplasmin (top panel) or anti-BiP (bottom 
panel) antiserum. (B) Protoplasts were co-transformed with plasmids 
encoding CLV3-GFP (top image, filled arrowhead) or mGFP5 (bottom image, 
empty arrowhead) and either of the proteins indicated at top, and then pulse-
labelled in the absence (-) or presence (+) of tunicamycin (Tm). 
Immunoselection was with anti-GFP antiserum. In panels A and B numbers at 
right indicate the positions of molecular mass markers, in kD. All samples in 
each of the four images were immunoselected from equal amounts of 
protoplasts. (C) Protoplasts were co-transformed with plasmids encoding 
mGFP5 or CLV3-GFP and either of the proteins indicated at bottom. 
Immunoprecipitation was with anti-GFP antiserum. After SDS-PAGE and 
fluorography, the intensity of the bands representing the GFP constructs was 
quantified. The graph shows the relative intensity of each sample derived 
from Tm-treated protoplasts with respect to that obtained from untreated 
protoplasts expressing mGFP5 + -amylase (mGFP5 samples) or CLV3-GFP 
+ -amylase (CLV3-GFP samples). (D) Protoplasts co-transformed with 
plasmid encoding CLV3-GFP and increasing amounts (from 0 to 20 µg) of 
plasmid encoding endoplasmin were incubated in the presence of Tm before 
pulse-labelling. Immunoprecipitation was with anti-GFP antiserum. The 
intensity of the bands representing CLV3-GFP was quantified. The graph 
shows the relative intensity of each sample with respect to that in the first 
column. (E) As in panel C, but without Tm treatment. In panels C, D and E 
bars represent standard deviations; values are the mean of four fully 
independent transformation experiments; one-way ANOVA analysis:  P<0.05 
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Fig. 2 CLV3-GFP does not perturb protein secretion and is stable when expressed in the cytosol. Tobacco leaf protoplasts were transformed with
plasmids encoding the proteins indicated in each panel. A–C: after pulse-labelling for 1 h, chase was performed for the indicated h. Protoplast
homogenates or, in panels A and B, homogenates of protoplasts (in) and their incubation medium (out) were immunoselected with anti-GFP serum.
After SDS-PAGE, radioactive proteins were detected. (D) Protoplasts were transfected with plasmids encoding the indicated proteins or empty
plasmid (Co). After incubation for 24 h, protoplasts (in) or incubation medium (out) were analysed by SDS-PAGE and protein blot with anti-GFP
serum. As a loading control, Ponceau S staining is also shown (bottom). Quantitation of CLV3Δsp-GFP or CLV3-GFP in two fully independent
protoplast transfections and protein blots is shown at right. In panels A–D, the positions of molecular mass markers (in kD) are shown at right.
Fig. 3 Fluorescence of CLV3-GFP is almost undetectable in protoplasts. Tobacco leaf protoplasts were transfected with plasmids encoding CLV3-
GFP or CLV3Δsp-GFP. After 24 h incubation, fluorescence of GFP or chloroplasts (Chl) was detected by epifluorescence microscopy. Two re-
presentative fields are shown for each transformation.
Fig. 6 The proteasome inhibitor MG132 increases CLV3-GFP stability. (A) Protoplasts isolated from leaves of wt tobacco (Co) or transgenic
tobacco expressing CLV3-GFP were incubated in the presence or absence of MG132 and pulse-labelled for 1 h. Protoplast homogenates were im-
munoselected with anti-GFP serum and analysed by SDS-PAGE and fluorography. The graph at right shows, for two fully independent experiments,
the relative intensity of radioactive bands, setting the value in the absence of MG132 to 100%. (B) Protoplasts isolated from leaves of transgenic
tobacco expressing Δ418 phaseolin were incubated in the presence or absence of MG132 and pulse-labelled for 1 h. Protoplast homogenates were
immunoselected with anti-phaseolin serum and analysed by SDS-PAGE and fluorography. (C) Pulse-chase of transgenic tobacco protoplast expressing
CLV3-GFP. Homogenates (in) and protoplast incubation medium (out) were immunoselected with anti-GFP anti-serum and analysed by SDS-PAGE
and fluorography. The graph at right reports quantitation of radioactive bands representing CLV3-GFP in three fully independent experiments,
setting the values at 0 h chase to 100%; error bar= ±SD. The positions of SDS-PAGE molecular mass markers (in kD) are indicated at left of the gel
images.
Fig. 8 CDC48QQ increases CLV3-GFP stability. Protoplasts prepared from leaves of transgenic tobacco expressing CLV3-GFP or Δ418 phaseolin
were co-transfected with plasmids encoding CDC48 wt or CDC48QQ. After pulse-labelling for 1 h with [35S]Met and [35S]Cys, protoplast homo-
genates were immunoselected with anti-GFP (CLV3-GFP) or anti-phaseolin (Δ418) serum and analysed by SDS-PAGE and fluorography. For CLV3-
GFP, the two images are derived from the same gel and same exposure, after removal of irrelevant lanes. The graphs show the average values of the
densitometry analysis from three independent experiments. Error bar= ±SD.
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